Pharma Focus Asia

One Key

Cegedim Relationship Management is pleased to update you on the progress of data optimization services in China.

With the release of the new healthcare reform plan in early April 2009, China is at a turning point. After many years of unequal medical access for the country?s poor, rural majority, which resulted in outbreaks of social unrest in recent years, the Chinese government has announced healthcare reform plans costing US $124bn over three years.

The China?s healthcare reform establishes a clear course, but the implications for healthcare players are not so obvious. On one hand, the healthcare sector will grow significantly. On the other hand, the government is encouraging patients to shift from urban hospitals to grassroots healthcare providers, and an important share of healthcare expenditure with it.

All these tremendous evolutions of the national healthcare system generate an impressive turnover, resulting in a really important need of support in the management of the data. With daily updates and constant validation services, OneKey Data Solution is set to answer to the current challenges of the market.

Download '.pdf' Format of the whitepaper.

Download Whitepapers
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Asia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024
Charles river - Endosafe Trillium